Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Rat TNF Receptor II ELISA Kit (AC2718)
Cat.#: ASET-1307
Specifications
Description Rat TNF Receptor II ELISA Kit allows for the in vitro quantitative determination of rat TNF Receptor II concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Rat Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.375 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 15.625-1000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2479 Rat ASRGL1 ELISA Kit (AC3890) Quantitative inquiry ASET-2476 Human Syndecan 4 ELISA Kit (AC3887) Quantitative inquiry ASET-1893 Mouse Contactin 1 ELISA Kit (AC3304) Quantitative inquiry ASET-1509 Rat PPAR gamma ELISA Kit (AC2920) Quantitative inquiry ASET-1991 Human SLC25A12 ELISA Kit (AC3402) Quantitative inquiry ASET-1309 Human Plasminogen Activator ELISA Kit (AC2720) Quantitative inquiry ASET-1962 Mouse Renalase ELISA Kit (AC3373) Quantitative inquiry ASET-1863 Human Oxytocin Receptor ELISA Kit (AC3274) Quantitative inquiry ASET-1745 Canine IL-6 ELISA Kit (AC3156) Quantitative inquiry ASET-2431 Estradiol ELISA Kit (AC3842) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket